Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $28.36 and last traded at $28.36, with a volume of 20,567 shares trading hands. The stock had previously closed at $27.61.

Several analysts have recently issued reports on the company. BidaskClub upgraded Assembly Biosciences from a “buy” rating to a “strong-buy” rating in a research note on Thursday, August 24th. Zacks Investment Research cut Assembly Biosciences from a “hold” rating to a “sell” rating in a research note on Monday, August 14th. Finally, Chardan Capital assumed coverage on Assembly Biosciences in a research note on Tuesday, May 30th. They issued a “buy” rating and a $35.00 price objective on the stock.

The company’s market cap is $492.62 million. The stock’s 50 day moving average is $24.17 and its 200 day moving average is $23.53.

A number of large investors have recently bought and sold shares of ASMB. State Street Corp purchased a new position in Assembly Biosciences in the 2nd quarter valued at about $4,234,000. JPMorgan Chase & Co. purchased a new position in Assembly Biosciences in the 2nd quarter valued at about $3,426,000. Northern Trust Corp boosted its position in Assembly Biosciences by 221.2% in the 2nd quarter. Northern Trust Corp now owns 195,321 shares of the biopharmaceutical company’s stock valued at $4,033,000 after buying an additional 134,513 shares during the last quarter. AXA purchased a new position in Assembly Biosciences in the 2nd quarter valued at about $2,477,000. Finally, Vanguard Group Inc. boosted its position in Assembly Biosciences by 21.2% in the 2nd quarter. Vanguard Group Inc. now owns 610,916 shares of the biopharmaceutical company’s stock valued at $12,615,000 after buying an additional 107,065 shares during the last quarter. 72.27% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This news story was posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://www.dailypolitical.com/2017/09/07/assembly-biosciences-inc-asmb-sets-new-52-week-high-at-28-36.html.

Assembly Biosciences Company Profile

Assembly Biosciences, Inc is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.